Attitudes and Perceptions of Biomedical HIV Prevention Methods: Voices from Young Men Who Have Sex with Men

Archives of Sexual Behavior

Volumn 44, Issue 2, 2015, Pages 487-497

  Kubicek, Katrina ^a   Arauz Cuadra, Cesar ^a   Kipke, Michele D ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

HIV; Pre exposure prophylaxis (PrEP); Rectal microbicides; Sexual orientation; Young men who have sex with men

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ATTITUDE TO HEALTH; ETHNOLOGY; HEALTH PROMOTION; HISPANIC; HIV INFECTIONS; HUMAN; INFORMATION PROCESSING; MALE; MALE HOMOSEXUALITY; PILOT STUDY; PSYCHOLOGY; QUALITATIVE RESEARCH; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HISPANIC AMERICANS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PILOT PROJECTS; QUALITATIVE RESEARCH; UNITED STATES; YOUNG ADULT;

EID: 84925484070     PISSN: 00040002     EISSN: 15732800     Source Type: Journal    
DOI: 10.1007/s10508-014-0398-8     Document Type: Article

References (37)

1. Belzer, M. E., Fuchs, D. N., Luftman, G. S., & Tucker, D. J. (1999). Antiretroviral adherence issues among HIV-positive adolescents and young adults. Journal of Adolescent Health,25(5), 316–319.
2. Bingham, T. A. (2005). Los Angeles men’s survey 2003–2004: HIV prevention and unrecognized HIV infection by race/ethnicity and age group. Los Angeles: Los Angeles County Department of Health Services.
3. Brooks, R. A., Landiovitz, R. J., Kaplan, R. L., Lieber, E., Lee, S. J., & Barkley, T. W. (2012). Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: A mixed methods study. AIDS Patient Care and STDs,26(2), 87–94.
4. Carballo-Dieguez, A., Dolezal, C., Bauermeister, J. A., O’Brien, W., Ventuneac, A., & Mayer, K. (2008). Preference for gel over suppository as delivery vehicle for a rectal microbicide: Results of a randomised, crossover acceptability trial among men who have sex with men. Sexually Transmitted Diseases,84(6), 483–487.
5. Carballo-Dieguez, A., Stein, Z., Saez, H., Dolezal, C., Nieves-Rosa, L. E., & Diaz, F. (2000). Frequent use of lubricants for anal sex among men who have sex with men: The HIV prevention potential of a microbicidal gel. American Journal of Public Health,90(7), 1117–1121.
6. Centers for Disease Control and Prevention. (2009). HIV prevention in the United States: At a critical crossroads. U.S. Department of Health and Human Services.
7. Centers for Disease Control and Prevention. (2010). HIV surveillance in men who have sex with men. Retrieved from http://www.cdc.gov/hiv/topics/surveillance/. Accessed 12 Nov 2014.
8. Centers for Disease Control and Prevention. (2013). Pre-exposure prophylaxis. Retrieved from http://www.cdc.gov/hiv/pdf/PrEP_fact_sheet_final.pdf. Accessed 5 Sept 2014.
9. Cranston, R. D., & Lama, J. R. (2012). A phase 2 randomized sequence open label expanded safety and acceptability study of oral emtricitabine/tenofir disoproxil fumarate tablet and rectally applied tenofovir reduced-glycerin 1 % gel. Thailand, USA, South Africa, Puerto Rico & Peru: National Institutes of Health.
10. Eisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012). Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PLoS ONE,7(1), e28238. doi:10.1371/journal.pone.0028238.
11. Gilead Science. (2011). Truvada for PrEP medication assistance program. Retrieved from http://www.gilead.com/responsibility/us-patient-access/truvada%20for%20prep%20medication%20assistance%20program. Accessed 4 Jan 2015.
12. Glaser, B. G. (1992). Basics of grounded theory analysis: Emergence vs forcing. Mill Valley, CA: Sociology Press.
13. Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS,27(4), 248–254. doi:10.1089/apc.2012.0419.
14. Gomez, G. B., Borquez, A., Case, K. K., Wheelock, A., Vassall, A., & Hankins, C. (2013). The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: A systematic review of cost-effectiveness modelling studies. PLoS Med,10(3), e1001401. doi:10.1371/journal.pmed.1001401.
15. Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi: doi:10.1056/NEJMoa1011205
16. Horberg, M., & Raymond, B. (2013). Financial policy issues for HIV pre-exposure prophylaxis: Cost and access to insurance. American Journal of Preventive Medicine, 44(1, Suppl. 2), S125–S128.
17. Hosek, S. G., Green, K. R., Siberry, G., Lally, M., Balthazar, C., Serrano, P. A., et al. (2013a). Integrating behavioral HIV interventions into biomedical prevention trials with youth: Lessons from Chicago’s Project PrEPare. Journal of HIV/AIDS & Social Services,12(3–4), 333–348. doi:10.1080/15381501.2013.773575.
18. Hosek, S. G., Siberry, G., Bell, M., Lally, M., Kapogiannis, B., Green, K., … Adolescent Trials Network for HIV/AIDS Intervention. (2013b). The acceptability and feasibility of an HIV pre-exposure prophylaxis (PrEP) trial with young men who have sex with men (YMSM). Journal of Acquired Immune Deficiency Syndromes, 62(4), 447–456.
19. Javanbakht, M., Murphy, R., Gorbach, P., LeBlanc, M., & Pickett, J. (2010). Preference and practices relating to lubricant use during anal intercourse: Implications for rectal microbicides. Sexual Health, 7(2), 193–198. doi: 10.1071/SH09062
20. Khawcharoenporn, T., Kendrick, S., & Smith, K. (2012). HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic. AIDS Patient Care and STDS,26(4), 222–233. doi:10.1089/apc.2011.0202.
21. Kippax, S., Reis, E., & de Wit, J. (2011). Two sides to the HIV prevention coin: Efficacy and effectiveness. AIDS Education and Prevention, 23(5), 393–396.
22. Kubicek, K., Carpineto, J., McDavitt, B., Weiss, G., Au, C. W., Kerrone, D., … Kipke, M. D. (2008). Integrating professional and folk models of HIV risk: YMSM’s perceptions of high-risk sex. AIDS Education and Prevention, 20(3), 220–238.
23. Mantella, J. E., Myerc, L., Carballo-Dieguez, A., Stein, Z., Ramjeee, G., Morare, N. S., et al. (2005). Microbicide acceptability research: Current approaches and future directions. Social Science and Medicine,60, 319–330.
24. McGowan, I. (2011). Rectal microbicides: Can we make them and will people use them? AIDS and Behavior,15(1), 66–71.
25. Mimiaga, M. J., Case, P., Johnson, C. V., Safren, S. A., & Mayer, K. H. (2009). Pre-exposure antiretroviral prophylaxis (PrEP) attitudes in high risk Boston area MSM: Limited knowledge and experience, but potential for increased utilization after education. Journal of Acquired Immune Deficiency Syndromes,50(1), 77–83.
26. Murphy, D. A., Wilson, C. M., Durako, S. J., Muenz, L. R., & Belzer, M. (2001). Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care,13(1), 27–40. doi:10.1080/09540120020018161.
27. Parsons, J. T., Grov, C., & Golub, S. A. (2012). Sexual compulsivity, co-occurring psychosocial health problems, and HIV risk among gay and bisexual men: Further evidence of a syndemic. American Journal of Public Health,102(1), 156–162.
28. Patton, M. Q. (2002). Qualitative evaluation and research methods. London: Sage Publications.
29. Pinkerton, S. D., & Abramson, P. R. (1997). Effectiveness of condoms in preventing HIV transmission. Social Science and Medicine,44(9), 303–312.
30. Rucinski, K. B., Mensah, N. P., Sepkowitz, K. A., Cutler, B. H., Sweeney, M. M., & Myers, J. E. (2013). Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS and Behavior,17, 2180–2184. doi:10.1007/s10461-013-0443-y.
31. Smith, D. K., Toledo, L., Smith, D. J., Adams, M. A., & Rothenberg, R. (2012). Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Education and Prevention,24(5), 408–421. doi:10.1521/aeap.2012.24.5.408.
32. Strauss, A., & Corbin, J. (1990). Grounded theory research: Procedures, canons, and evaluative criteria. Qualitative Sociology,13(1), 3–21.
33. Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. doi:10.1056/NEJMoa1110711
34. van der Straten, A., Van Damme, L., Haberer, J. E., & Bangsberg, D. R. (2012). Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS,26(7), F13–F19. doi:10.1097/QAD.1090b1013e3283522272.
35. Verguet, S., & Walsh, J. A. (2010). Vaginal microbicides save money: A model of cost-effectiveness in South Africa and the USA. Sexually Transmitted Infections,86(3), 212–216. doi:10.1136/sti.2009.037176.
36. Whiteside, Y. O., Harris, T., Scanlon, C., Clarkson, S., & Duffus, W. (2011). Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina. AIDS Patient Care and STDS,25(6), 365–370. doi:10.1089/apc.2010.0224.
37. Young, I., & McDaid, L. (2014). How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS and Behavior,18(2), 195–216. doi:10.1007/s10461-013-0560-7.